Synapse Association Hosts Grand Opening Event of Mental Health Clinic in Davis, California
Mayor Brett Lee to attend event and lead ribbon cutting ceremony
DAVIS, Calif., Feb. 5, 2019 /PRNewswire/ -- Synapse Association, a behavioral health clinic offering cutting edge treatments and evaluations spanning a wide spectrum of mental illnesses, announced today that it will celebrate the grand opening of its facility with a ribbon cutting ceremony on February 7. The facility will offer a variety of treatment options including suboxone induction treatment, cognitive behavioral therapy (CBT) and BrainsWay's Deep Transcranial Magnetic Stimulation (Deep TMS), a non-invasive alternative to medication. Mayor Brett Lee of Davis, California will be in attendance at the event.
"Today, nearly 16 million Americans suffer from clinical depression, and it is important that we recognize this growing issue," said Mayor Lee. "I am pleased that this new clinic will offer additional treatment options for people in our area."
Dr. Mina Hah is triple-board certified in addiction medicine, adult psychiatry and child and adolescent psychiatry. In the new facility, she will offer treatment for addiction, attention-deficit hyperactivity disorder (ADHD), depression and anxiety. Servicing roughly half of patients suffering from depression, who do not respond to their antidepressant medication, Synapse Association is offering Deep TMS, an effective, non-invasive alternative to medication that stimulates the region of the brain responsible for depression. The facility will offer Deep TMS for depression at its opening and will incorporate the treatment for obsessive-compulsive disorder (OCD) at a later date.
"In California, over one million adults have serious thoughts of suicide – that is a tremendous number," said Mina Hah, M.D., founder and CEO of Synapse Association. "As a psychiatrist working in Yolo County and Sacramento County, I am eager to help those suffering in my local and surrounding communities. Recognizing the importance of tailored therapeutic options to meet the needs of each patient, I am proud to offer cutting edge alternative therapies to my patients to help them manage their mental illness."
The Grand Opening event is open to the public. Details about the event can be found below:
Date: Thursday, February 7, 2019
Time: 3:00 p.m. to 7:00 p.m.
Location: Synapse Association, 2056 Lyndell Terrace, Suite 130, Davis, CA, 95616
For more information: Call (530) 924-4038 or email [email protected]
About Synapse Association
Synapse Association is a behavioral health clinic offering cutting edge treatments for those suffering from mental illness including Deep Transcranial Magnetic Stimulation (Deep TMS), cognitive behavioral therapy (CBT) and suboxone induction treatment. Mina Hah, M.D., founder and chief executive officer of Synapse Associations offers evaluation and treatment spanning a wide spectrum of mental illnesses including anxiety disorders, autism spectrum, attention-deficit hyperactivity disorder (ADHD), substance abuse, depressive and bipolar disorders, eating disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), phobias and psychotic disorders. Dr. Hah is a triple board certified psychiatrist in Addiction Medicine, Adult Psychiatry and Child and Adolescent Psychiatry. She is also an Associate Professor and Psychiatry Clerkship Director at California Northstate University School of Medicine and teaches at UC Davis School of Medicine.
About BrainsWay
BrainsWay Ltd./ BrainsWay USA is engaged in the research, development and sales and marketing of a medical system for non-invasive treatment of common brain disorders. The medical system developed and manufactured by the company is based on a unique breakthrough technology called Deep TMS, which can reach significant depth and breadth of the brain and produce broad stimulation and functional modulation of targeted brain areas. In the U.S., the Company's device has been FDA cleared for the treatment of major depressive disorder (MDD) since 2013 and is now FDA cleared (De-Novo) for the treatment of Obsessive-Compulsive Disorder (OCD). The Company's systems have also received CE clearance and are sold worldwide for the treatment of various brain disorders.
Media Contact:
Nechama Feuerstein
[email protected]
201-373-2228
SOURCE Synapse Association
Share this article